Advertisement
Articles
Advertisement

Efficacy Seen For Stents With Dissolving Parts

Wed, 10/31/2012 - 5:55am
Chris Kaiser

In an effort to reduce the small but real risk of stent thrombosis associated with drug-eluting stents, stent makers have turned to devices whose polymer or scaffolding dissolves over time.

A series of studies reported at the Transcatheter Cardiovascular Therapeutics (TCT) meeting highlighted the latest results from bioabsorbable devices.

DESSOLVE II

The MiStent sirolimus-eluting biodegradable polymer stent (Micell Technologies) had a mean 0.27 mm late lumen loss at 9 months compared with 0.58 mm for the Endeavor zotarolimus-eluting durable polymer stent (Medtronic) (P<0.001 for superiority), according to David E. Kandzari, MD, of the Piedmont Heart Institute in Atlanta, and colleagues

Continue reading...

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading